Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10495198 | 0.90 | ALDH1A1 (0.89) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL104400 | 0.83 | KMT2A (0.78) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL12089434 | 0.83 | ALDH1A1 (0.78) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL10169258 | 0.83 | ALDH1A1 (0.96) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL1104737 | 0.83 | ALDH1A1 (0.90) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL26078951 | 0.82 | ALDH1A1 (0.76) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL23709723 | 0.82 | ALDH1A1 (0.76) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL13149732 | 0.81 | SMN1; SMN2 (0.62) | ALDH1A1KMT2ASMN1; SMN2POLBHPGD | |
| SCHEMBL10169253 | 0.81 | ALDH1A1 (0.87) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 | |
| SCHEMBL20883570 | 0.81 | PANK3 (0.56) | ALDH1A1KMT2AMEN1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142739-A1 | PROTEIN-PROTEIN INTERACTION STABILIZERS | UNIV CALIFORNIA (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230142739-A1 | PROTEIN-PROTEIN INTERACTION STABILIZERS | UNIV CALIFORNIA (US) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142739-A1 | PROTEIN-PROTEIN INTERACTION STABILIZERS | HSPBP1, HSPA8, HSPH1 | ALDH1A1 3889/4885KMT2A 3385/4885MEN1 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.